Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...

Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

The Global TB Report 2025 released by the World Health Organization (WHO) highlights that India’s TB incidence has reduced ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment.

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

Sorfequiline, previously known as TBAJ-876, was evaluated in combination with pretomanid and linezolid in a randomized, controlled trial in people with drug-sensitive TB COPENHAGEN (November 19, 2025) ...

The Department of Health is targeting to screen 12 million Filipinos nationwide in an effort to curb tuberculosis in the ...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...